Mortara Instrument Inc. of Milwaukee has signed an agreement to acquire the cardiac diagnostic product line from Cardiac Science, which is a part of Opto Circuits.
Cardiac Science has agreed to offer its support to diagnostic cardiology business during the transition period.
Diet, Lifestyle and Heart Disease
The correlation between diet, lifestyle and heart disease. The importance of balanced diet life style and exercise for controlling heart disease.
Advertisement
With this sale, Cardiac Science hopes to focus exclusively on its resuscitation-products business, having a high growth margin.
While Mortara Instrument Inc. hopes to utilize this acquisition to introduce its leading ECG technology into new markets.
The shares of Opto Circuits were hiked by 0.91% following this dealing.
Source: Medindia
The shares of Opto Circuits were hiked by 0.91% following this dealing.
Source: Medindia
Cardiac MRI Paves Way for Better Diagnosis in Patients With Grave Arrhythmias
Benefits of Cardiovascular Magnetic Resonance (CMR) engaged in patients who have been resuscitated after Sudden Cardiac Death or enter hospital suffering from abnormal heartbeat rhythm, demonstrated.
Advertisement
 New Risk Factor for Coronary Heart DiseaseDepression post heart disease can significantly increase the risk of death or another heart attack. | Advertisement
|
Advertisement
Recommended Readings
Latest Corporate News
The first World Health Organisation (WHO)/ International Labour Organisation (ILO) joint global monitoring report shows that more action is needed to ensure healthier, safer, more resilient, and more social workplaces.
Successful career transitions could be possible when people leverage their existing skills in the new occupation. A new Artificial Intelligence tool helps employees figure out the right job according to their current skill set.
AI and big data rule the pharmaceutical sector by enhancing the drug development process and increasing the marketing and sales of drugs
Insurance companies in the US are working towards adding food to their coverage menu to improve the people's health under their coverage and cut hospital costs.
Pharmaceutical companies need to make strategic decisions that will provide financial benefit while showing strong commitment to global health and their patients during the pandemic.
